{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:24:05Z","timestamp":1787747045756,"version":"build-2784847793"},"reference-count":30,"publisher":"Akademiai Kiado Zrt.","content-domain":{"domain":["www.akjournals.com"],"crossmark-restriction":true},"short-container-title":["AMICR"],"published-print":{"date-parts":[[2026,8,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chronic obstructive pulmonary disease (COPD) is featured by persistent airflow limitation and chronic inflammation. Considerable evidence highlights the role of the gut-lung axis, suggesting that disruption of gut microbial balance may contribute to aggravated systemic and pulmonary inflammation. This research intended to assess the impacts of a structured gut-lung axis-targeted nursing intervention on immune-inflammatory parameters, gut microbiota, and clinical outcomes in patients with stable COPD. The study involved the randomization of 115 patients to either the intervention or control group in a 1:1\u00a0ratio. The intervention group received a 12-week multimodal program, which included personalized high-fiber\/probiotic nutrition, customized exercise plans, and stress management techniques. Patients in the control group did not receive the multimodal program and instead received routine care. The\u00a0findings indicated that the intervention notably lowered serum IL-6, TNF-\u03b1, and CRP. Microbiome analysis further revealed that the intervention significantly enhanced\n                    <jats:italic>\u03b1<\/jats:italic>\n                    -diversity (Shannon and Chao1), enriched beneficial butyrate-producing genera (\n                    <jats:italic>Faecalibacterium<\/jats:italic>\n                    ,\n                    <jats:italic>Roseburia<\/jats:italic>\n                    , and\n                    <jats:italic>Bifidobacterium<\/jats:italic>\n                    ), and reduced the relative abundance of potential pathogens (\n                    <jats:italic>Enterobacteriaceae<\/jats:italic>\n                    ), indicating a favorable shift in gut microbial ecology. Compared with the control group, the intervention group also experienced fewer moderate-to-severe exacerbations and showed greater sustained improvement in quality of life (SGRQ and CAT scores). In summary, a comprehensive nursing strategy centered on the gut-lung axis can regulate gut microbiota, alleviate systemic inflammation, lead to a reduction in exacerbation frequency and an improvement in the quality of life among patients with stable COPD, thus presenting a promising supplementary strategy to conventional care.\n                  <\/jats:p>","DOI":"10.1556\/030.2026.02947","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:05:31Z","timestamp":1787745931000},"update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":0,"title":["The role of gut-lung axis-targeted nursing strategies in immune regulation of COPD"],"prefix":"10.1556","author":[{"given":"Rui","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine Nurse, Hangzhou Xixi Hospital, No. 2, Hengbu Street, Xihu District, Hangzhou City, Zhejiang Province, 310063, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuxiu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Respiratory physician, Hangzhou Xixi Hospital, No. 2, Hengbu Street, Xihu District, Hangzhou City, Zhejiang Province, 310063, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7749-2783","authenticated-orcid":true,"given":"Yao","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Nurse, Hangzhou Xixi Hospital, No. 2, Hengbu Street, Xihu District, Hangzhou City, Zhejiang Province, 310063, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"B1","series-title":"Front Med (Lausanne)","article-title":"Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990-2021: an age-period-cohort analysis based on the global burden of disease study 2021","volume":"12","author":"Cao W","year":"2025","unstructured":"Cao W, Zheng J, Li Q, Guo D, Fan X, Zhu G, et\u00a0al. Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990-2021: an age-period-cohort analysis based on the global burden of disease study 2021. Front Med (Lausanne) 2025; 12: 1554442."},{"issue":"9859","key":"B2","series-title":"Lancet","first-page":"2095","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Lozano R","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et\u00a0al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012; 380(9859): 2095\u2013128."},{"issue":"1","key":"B3","series-title":"J Allergy Clin Immunol","first-page":"16","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes PJ","year":"2016","unstructured":"Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 2016; 138(1): 16\u201327."},{"issue":"9823","key":"B4","series-title":"Lancet","first-page":"1341","article-title":"Chronic obstructive pulmonary disease","volume":"379","author":"Decramer M","year":"2012","unstructured":"Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379(9823): 1341\u201351."},{"key":"B5","series-title":"Front Cell Infect Microbiol","article-title":"Gut microbiome dysbiosis in chronic lung disease: a systematic review and meta-analysis","volume":"15","author":"Pan J","year":"2025","unstructured":"Pan J, Zhang Y, Qiu S, Peng S, Kang H, Tung TH, et\u00a0al. Gut microbiome dysbiosis in chronic lung disease: a systematic review and meta-analysis. Front Cell Infect Microbiol 2025; 15: 1554846."},{"key":"B6","series-title":"Int J Chron Obstruct Pulmon Dis","first-page":"643","article-title":"Genetic insights into the gut-lung axis: mendelian randomization analysis on gut Microbiota, lung function, and COPD","volume":"19","author":"Cheng ZX","year":"2024","unstructured":"Cheng ZX, Hua JL, Jie ZJ, Li XJ, Zhang J. Genetic insights into the gut-lung axis: mendelian randomization analysis on gut Microbiota, lung function, and COPD. Int J Chron Obstruct Pulmon Dis 2024; 19: 643\u201353."},{"key":"B7","series-title":"Front Cell Infect Microbiol","article-title":"Respiratory diseases and the gut microbiota: an updated review","volume":"15","author":"Yu X","year":"2025","unstructured":"Yu X, Yu X, Wang Y, Guo X, Wang C, Wang F. Respiratory diseases and the gut microbiota: an updated review. Front Cell Infect Microbiol 2025; 15: 1629005."},{"issue":"7","key":"B8","series-title":"Microorganisms","first-page":"1428","article-title":"Probiotics: protecting our health from the gut","volume":"10","author":"Varela-Trinidad GU","year":"2022","unstructured":"Varela-Trinidad GU, Dom\u00ednguez-D\u00edaz C, Sol\u00f3rzano-Castanedo K, \u00cd\u00f1iguez-Guti\u00e9rrez L, Hern\u00e1ndez-Flores TJ, Fafutis-Morris M. Probiotics: protecting our health from the gut. Microorganisms 2022; 10(7): 1428."},{"issue":"4","key":"B9","series-title":"Chronic Obstr Pulm Dis","first-page":"339","article-title":"Challenges and opportunities for the management of COPD: a narrative review of patient and health care professional perspectives","volume":"12","author":"Anzueto A","year":"2025","unstructured":"Anzueto A, Hoy H, Gainer C. Challenges and opportunities for the management of COPD: a narrative review of patient and health care professional perspectives. Chronic Obstr Pulm Dis 2025; 12(4): 339\u201356."},{"issue":"3","key":"B10","series-title":"Int\u00a0J\u00a0Nurs Pract","article-title":"Impact of telecounselling, home monitoring and exercise on hospital readmissions and quality of life in chronic obstructive pulmonary disease: a randomized controlled trial","volume":"31","author":"K\u00f6ksal N","year":"2025","unstructured":"K\u00f6ksal N, Durgun H. Impact of telecounselling, home monitoring and exercise on hospital readmissions and quality of life in chronic obstructive pulmonary disease: a randomized controlled trial. Int\u00a0J\u00a0Nurs Pract 2025; 31(3): e70021."},{"key":"B11","series-title":"Front Immunol","article-title":"Immune cell regulatory networks in chronic obstructive pulmonary disease: mechanistic analysis from innate to adaptive immunity","volume":"16","author":"Li H","year":"2025","unstructured":"Li H, Wang Y, Duan H, Bao Y, Deng X, He Y, et\u00a0al. Immune cell regulatory networks in chronic obstructive pulmonary disease: mechanistic analysis from innate to adaptive immunity. Front Immunol 2025; 16: 1651808."},{"key":"B12","series-title":"Front Immunol","article-title":"The gut-lung axis: effects and mechanisms of gut microbiota on pulmonary diseases","volume":"16","author":"Liu J","year":"2026","unstructured":"Liu J, Hong W, Sun Z, Zhang S, Xue C, Dong N. The gut-lung axis: effects and mechanisms of gut microbiota on pulmonary diseases. Front Immunol 2026; 16: 1693964."},{"key":"B13","series-title":"Front Immunol","article-title":"Chronic obstructive pulmonary disease: in-depth analysis of microbiota association and innovative prevention and treatment approaches from the gut-lung axis perspective","volume":"16","author":"Wang Y","year":"2025","unstructured":"Wang Y, Li X, Gao F. Chronic obstructive pulmonary disease: in-depth analysis of microbiota association and innovative prevention and treatment approaches from the gut-lung axis perspective. Front Immunol 2025; 16: 1549865."},{"key":"B14","series-title":"Front Cell Infect Microbiol","article-title":"Effects of probiotic treatment on patients and animals with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized control trials","volume":"14","author":"Su Z","year":"2024","unstructured":"Su Z, Ma C, Ru X, Zhang S, Wu C, Huang Y, et\u00a0al. Effects of probiotic treatment on patients and animals with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized control trials. Front Cell Infect Microbiol 2024; 14: 1411222."},{"key":"B15","series-title":"Front Immunol","first-page":"2144","article-title":"Links between inflammatory bowel disease and chronic obstructive pulmonary disease","volume":"11","author":"Raftery AL","year":"2020","unstructured":"Raftery AL, Tsantikos E, Harris NL, Hibbs ML. Links between inflammatory bowel disease and chronic obstructive pulmonary disease. Front Immunol 2020; 11: 2144."},{"issue":"11","key":"B16","series-title":"Nan Fang Yi Ke Da Xue Xue Bao","first-page":"2156","article-title":"Liuwei Buqi Formula delays progression of chronic obstructive pulmonary disease in rats by regulating the NLRP3\/caspase-1\/GSDMD pyroptosis pathway","volume":"44","author":"Mei L","year":"2024","unstructured":"Mei L, Zhang L, Wu D, Ding H, Wang X, Zhang X, et\u00a0al. Liuwei Buqi Formula delays progression of chronic obstructive pulmonary disease in rats by regulating the NLRP3\/caspase-1\/GSDMD pyroptosis pathway. Nan Fang Yi Ke Da Xue Xue Bao 2024; 44(11): 2156\u201362."},{"issue":"22","key":"B17","series-title":"FEBS J","first-page":"6134","article-title":"Butyrate suppresses mucosal inflammation in inflammatory bowel disease primarily through HDAC3 inhibition in monocytes and macrophages","volume":"292","author":"Parada-Venegas D","year":"2025","unstructured":"Parada-Venegas D, De la Fuente L\u00f3pez M, Dubois-Camacho K, Landskron G, Blokzijl T, Molina H, et\u00a0al. Butyrate suppresses mucosal inflammation in inflammatory bowel disease primarily through HDAC3 inhibition in monocytes and macrophages. FEBS J 2025; 292(22): 6134\u201357."},{"issue":"8","key":"B18","series-title":"Nutrients","first-page":"1305","article-title":"Beyond the gut: unveiling butyrate's global health impact through gut health and dysbiosis-related conditions: a narrative review","volume":"17","author":"Kalkan AE","year":"2025","unstructured":"Kalkan AE, BinMowyna MN, Raposo A, Ahmad MF, Ahmed F, Otayf AY, et\u00a0al. Beyond the gut: unveiling butyrate's global health impact through gut health and dysbiosis-related conditions: a narrative review. Nutrients 2025; 17(8): 1305."},{"key":"B19","series-title":"Front Microbiol","article-title":"Early life administration of Bifidobacterium bifidum BD-1 alleviates long-term colitis by remodeling the gut microbiota and promoting intestinal barrier development","volume":"13","author":"Peng C","year":"2022","unstructured":"Peng C, Li J, Miao Z, Wang Y, Wu S, Wang Y, et\u00a0al. Early life administration of Bifidobacterium bifidum BD-1 alleviates long-term colitis by remodeling the gut microbiota and promoting intestinal barrier development. Front Microbiol 2022; 13: 916824."},{"issue":"2","key":"B20","series-title":"Mucosal Immunol","first-page":"353","article-title":"Impact of smoking on gut microbiota and short-chain fatty acids in human and mice: implications for COPD","volume":"18","author":"Otake S","year":"2025","unstructured":"Otake S, Chubachi S, Miyamoto J, Haneishi Y, Arai T, Iizuka H, et\u00a0al. Impact of smoking on gut microbiota and short-chain fatty acids in human and mice: implications for COPD. Mucosal Immunol 2025; 18(2): 353\u201365."},{"issue":"6","key":"B21","series-title":"Cytotechnology","first-page":"188","article-title":"Immunomodulatory effects of short-chain fatty acids in chronic obstructive pulmonary disease: rebalancing Th17\/Treg axis and enhancing epithelial repair","volume":"77","author":"Li X","year":"2025","unstructured":"Li X, Jing Z, Li S, Wang J, Liu J. Immunomodulatory effects of short-chain fatty acids in chronic obstructive pulmonary disease: rebalancing Th17\/Treg axis and enhancing epithelial repair. Cytotechnology 2025; 77(6): 188."},{"key":"B22","series-title":"Mol Immunol","first-page":"224","article-title":"Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-\u03baB\/MAPKs signaling pathways","volume":"163","author":"Zhao Z","year":"2023","unstructured":"Zhao Z, Tong Y, Kang Y, Qiu Z, Li Q, Xu C, et\u00a0al. Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-\u03baB\/MAPKs signaling pathways. Mol Immunol 2023; 163: 224\u201334."},{"issue":"12","key":"B23","series-title":"Cochrane Database Syst Rev","article-title":"Pharmacological interventions\u00a0for the treatment of depression in chronic obstructive pulmonary disease","volume":"12","author":"Pollok J","year":"2018","unstructured":"Pollok J, van Agteren JE, Carson-Chahhoud KV. Pharmacological interventions\u00a0for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2018; 12(12): CD012346."},{"issue":"3","key":"B24","series-title":"Chest","first-page":"494","article-title":"Reduced COPD exacerbation risk correlates with improved FEV1: a meta-regression analysis","volume":"152","author":"Zider AD","year":"2017","unstructured":"Zider AD, Wang X, Buhr RG, Sirichana W, Barjaktarevic IZ, Cooper CB. Reduced COPD exacerbation risk correlates with improved FEV1: a meta-regression analysis. Chest 2017; 152(3): 494\u2013501."},{"key":"B25","series-title":"EBioMedicine","article-title":"Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease","volume":"123","author":"Viglino J","year":"2026","unstructured":"Viglino J, Perea L, Garcia-Nu\u00f1ez M, Rodrigo-Troyano A, Torrego A, Dom\u00ednguez-Alvarez M, et\u00a0al. Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease. EBioMedicine 2026; 123: 106099."},{"issue":"5","key":"B26","series-title":"Life (Basel)","first-page":"750","article-title":"Increasing quality and quantity of life in individuals with chronic obstructive pulmonary disease: a narrative review with an emphasis on pulmonary rehabilitation","volume":"15","author":"Lareau S","year":"2025","unstructured":"Lareau S, ZuWallack R, Nici L. Increasing quality and quantity of life in individuals with chronic obstructive pulmonary disease: a narrative review with an emphasis on pulmonary rehabilitation. Life (Basel) 2025; 15(5): 750."},{"key":"B27","series-title":"Int J Chron Obstruct Pulmon Dis","first-page":"1059","article-title":"Reduction of exacerbation frequency in patients with COPD\u00a0after participation in a comprehensive pulmonary rehabilitation program","volume":"9","author":"van Ranst D","year":"2014","unstructured":"van Ranst D, Stoop WA, Meijer JW, Otten HJ, van de Port IG. Reduction of exacerbation frequency in patients with COPD\u00a0after participation in a comprehensive pulmonary rehabilitation program. Int J Chron Obstruct Pulmon Dis 2014; 9: 1059\u201367."},{"issue":"1","key":"B28","series-title":"BMJ Open Respir Res","article-title":"Self-management programme of activity coping and education-SPACE for COPD(C)-in primary care: a pragmatic randomised trial","volume":"9","author":"Bourne C","year":"2022","unstructured":"Bourne C, Houchen-Wolloff L, Patel P, Bankart J, Singh S. Self-management programme of activity coping and education-SPACE for COPD(C)-in primary care: a pragmatic randomised trial. BMJ Open Respir Res 2022; 9(1): e001443."},{"issue":"10","key":"B29","series-title":"Nutrients","first-page":"1515","article-title":"Combined lifestyle interventions in the prevention and management of asthma and COPD: a systematic review","volume":"16","author":"Born CDC","year":"2024","unstructured":"Born CDC, Bhadra R, D'Souza G, Kremers SPJ, Sambashivaiah S, Schols AMWJ, et\u00a0al. Combined lifestyle interventions in the prevention and management of asthma and COPD: a systematic review. Nutrients 2024; 16(10): 1515."},{"issue":"6","key":"B30","series-title":"Respir Care","first-page":"960","article-title":"Feasibility of a health coaching and home-based rehabilitation intervention with remote monitoring for COPD","volume":"66","author":"Benzo RP","year":"2021","unstructured":"Benzo RP, Ridgeway J, Hoult JP, Novotny P, Thomas BE, Lam NM, et\u00a0al. Feasibility of a health coaching and home-based rehabilitation intervention with remote monitoring for COPD. Respir Care 2021; 66(6): 960\u201371."}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"link":[{"URL":"https:\/\/www.akjournals.com\/view\/journals\/030\/aop\/article-10.1556-030.2026.02947\/article-10.1556-030.2026.02947.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/030\/aop\/article-10.1556-030.2026.02947\/article-10.1556-030.2026.02947.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:05:31Z","timestamp":1787745931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.akjournals.com\/view\/journals\/030\/aop\/article-10.1556-030.2026.02947\/article-10.1556-030.2026.02947.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1556\/030.2026.02947","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"value":"1217-8950","type":"print"},{"value":"1588-2640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}